Suppr超能文献

生物活性玻璃在盖髓治疗中是否有效?:一项为期一年随访的随机对照临床试验。

Is Bioactive Glass an Effective Agent in Pulp-capping Treatments?: A Randomized Controlled Clinical Trial with One-year Follow-up.

机构信息

Faculty of Dentistry, Department of Pediatric Dentistry, Necmettin Erbakan University, Konya, Turkey, Phone: +90 5065803056, e-mail:

Faculty of Dentistry, Department of Pediatric Dentistry, Necmettin Erbakan University, Konya, Turkey, Orcid: https://orcid.org/0000-0001-6976-3071.

出版信息

J Contemp Dent Pract. 2022 Nov 1;23(11):1128-1135. doi: 10.5005/jp-journals-10024-3428.

Abstract

AIMS

Indirect pulp-capping treatment is a procedure applied to teeth with deep and close-to-pulp caries lesions and without pulp degeneration symptoms. This study aimed to explore the use of a material containing bioactive glass for indirect pulp capping in primary and permanent teeth.

MATERIALS AND METHODS

The study included 145 patients, aged 4-15 years, without any systemic disease and 100 primary second molars and 100 permanent first molars in total. Four material groups were determined: calcium hydroxide (Dycal-DC group), glass ionomer (Biner LC-BC group), calcium silicate (TheraCal LC-TC group), and Bioactive glass-containing ACTIVA BioACTIVE-AC group. Clinical and radiographic evaluations were made 1, 3, 6, 9, and 12 months after the treatment. The data obtained were statistically analyzed using the Chi-square test.

RESULTS

During the 12-month follow-up period, the DC and TC groups were more successful clinically (94%), while the DC and AC groups were found to be more successful radiographically (94%). However, no statistically significant difference was found between the groups ( > 0.05).

CONCLUSIONS

The results of this study supported the view that the success of indirect pulp-capping treatments was independent of the material used.

CLINICAL SIGNIFICANCE

This study demonstrated that a material containing bioactive glass, ACTIVA BioACTIVE-Base/Liner, can be used safely in indirect pulp-capping processes.

摘要

目的

间接盖髓治疗适用于深龋接近牙髓且无牙髓病变症状的患牙。本研究旨在探讨应用含有生物活性玻璃的材料进行乳恒牙间接盖髓。

材料和方法

共纳入无系统性疾病的 145 例 4-15 岁患者,共计 100 颗乳第二磨牙和 100 颗恒第一磨牙。将其分为 4 个材料组:氢氧化钙(Dycal-DC 组)、玻璃离子水门汀(Biner LC-BC 组)、硅酸钙(TheraCal LC-TC 组)和含生物活性玻璃的 ACTIVA BioACTIVE-AC 组。在治疗后 1、3、6、9 和 12 个月进行临床和影像学评估。使用卡方检验对获得的数据进行统计学分析。

结果

在 12 个月的随访期间,DC 和 TC 组的临床成功率较高(94%),而 DC 和 AC 组的影像学成功率较高(94%)。然而,各组之间无统计学差异(>0.05)。

结论

本研究结果支持间接盖髓治疗的成功率与材料无关的观点。

临床意义

本研究表明,含生物活性玻璃的 ACTIVA BioACTIVE-Base/Liner 材料可安全地用于间接盖髓过程。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验